Erzotabart Antibody
Erzotabart is an investigational IgG1-kappa monoclonal antibody targeting human CD38. Its antineoplastic activity, demonstrated in preclinical studies, stems from disrupting CD38-mediated pathways crucial for tumor cell proliferation, metabolism, and immune evasion in oncology research.
Product Specifications
Product Name Alternative
GEN 3014, GEN3014
Target
CD38
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.18 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.01 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15151753 1 Vial
Lentiviral human RBM3 shRNA (UAS) - Lentiviral human RBM3 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details